Search Results
Jun 09, 2026, 06:00 ET Josh Bersin Company Reinvents HR Certification with AI-Driven, Real-World Learning and 35 Years of Research
usual—it's HR capability development under real-world pressure, powered by AI and grounded in how business actually works. And we will stand behind our JBI-certified professionals to make sure employers understand their depth and value as HR leaders."To learn more about The Josh Bersin Institute
More news about: The Josh Bersin Company
May 14, 2026, 09:00 ET Young Black and Hispanic Americans Aspire to Homeownership, Entrepreneurship, and Generational Wealth at Higher Rates Than White Peers -- but Face Steeper Structural Barriers
financial marketplace by 2050. Lenders that don't adapt to this reality will be left behind," said Mitria Spotser, president of JBI and a report co-author. The JBI 2050 Survey, conducted by NORC at the University of Chicago, surveyed 5,269 Americans, oversampling white, Black, Hispanic, and Asian
More news about: Julian Bond Institute
Dec 05, 2025, 08:00 ET Jubilant Therapeutics Inc. appoints Daniel J. O'Connor as President and Chief Executive Officer
Optimization), has been validated through successful partnerships. The Company's clinical pipeline consists of a first in class dual CoREST modifier, JBI-802, currently in a Phase I/II clinical trial in multiple tumors and a novel brain-penetrant modulator of PRMT5, currently in Phase I clinical trial. Additional
More news about: Jubilant Therapeutics Inc.